She-Juan An

1.2k total citations
7 papers, 453 citations indexed

About

She-Juan An is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, She-Juan An has authored 7 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in She-Juan An's work include Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and HER2/EGFR in Cancer Research (2 papers). She-Juan An is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and HER2/EGFR in Cancer Research (2 papers). She-Juan An collaborates with scholars based in China and Hong Kong. She-Juan An's co-authors include Tony Mok, Yi‐Long Wu, Xu‐Chao Zhang, Zhi Hong Chen, Jian Su, Wen‐Zhao Zhong, Qing Zhou, Ailin Guo, Rong Li and Qiang Nie and has published in prestigious journals such as PLoS ONE, European Journal of Pharmacology and Cancer Letters.

In The Last Decade

She-Juan An

7 papers receiving 442 citations

Peers

Countries citing papers authored by She-Juan An

Since Specialization

Citations

This map shows the geographic impact of She-Juan An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by She-Juan An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites She-Juan An more than expected).

Fields of papers citing papers by She-Juan An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by She-Juan An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by She-Juan An. The network helps show where She-Juan An may publish in the future.

Co-authorship network of co-authors of She-Juan An

This figure shows the co-authorship network connecting the top 25 collaborators of She-Juan An. A scholar is included among the top collaborators of She-Juan An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with She-Juan An. She-Juan An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status 2012 ·PLoS ONE ·She-Juan An, Zhi Hong Chen, Jian Su, Xu‐Chao Zhang, (unknown), (unknown), Qing Zhou, (unknown), Ling Huang, (unknown), Qiang Nie, (unknown), Tony Mok, Yi‐Long Wu	140
2	EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas 2012 ·The Oncologist ·Zhiyong Chen, Wen‐Zhao Zhong, Xu‐Chao Zhang, Jian Su, Xue-Ning Yang, Zhi Hong Chen, Jin-Ji Yang, Qing Zhou, (unknown), She-Juan An, (unknown), Ben‐Yuan Jiang, Tony Mok, Yi‐Long Wu	133
3	Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients 2008 ·Human Pathology ·Rong Li, She-Juan An, Zhi Hong Chen, Guochun Zhang, (unknown), Qiang Nie, Zhi Xie, Ailin Guo, Tony Mok, Yi‐Long Wu	29
4	Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals 2008 ·Cancer Letters ·Jianquan Zhu, Wen‐Zhao Zhong, Guochun Zhang, Rong Li, Xu‐Chao Zhang, Ailin Guo, (unknown), She-Juan An, Tony Mok, Yi‐Long Wu	103
5	KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer 2007 ·Journal of Cancer Research and Clinical Oncology ·She-Juan An, Qiang Nie, Zhi Hong Chen, (unknown), Zhen Wang, Zhi Xie, (unknown), Ying Huang, (unknown), (unknown), (unknown), (unknown), Rong Li, Xu‐Chao Zhang, Ailin Guo, Tony Mok, Yi‐Long Wu	14
6	The epidermal growth factor receptor intron1 (CA) n microsatellite polymorphism is a potential predictor of treatment outcome in patients with advanced lung cancer treated with Gefitinib 2007 ·European Journal of Pharmacology ·Qiang Nie, Zhen Wang, Guochun Zhang, She-Juan An, (unknown), Ailin Guo, Rong Li, Bin Gan, Ying Huang, Tony Mok, Yi‐Long Wu	30
7	Characterization of 67 kD Laminin Receptor, a Protein Whose Gene Is Overexpressed on Treatment of Cells with Anti-Benzo[a]pyrene-7,8-Diol-9,10-Epoxide 2006 ·Toxicological Sciences ·She-Juan An, Jia‐Kun Chen, (unknown), (unknown), Yiguo Jiang, Qing-Yi Wei, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact